It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Moderna Inc.’s stock fell 2.9% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered ...

please reach out to the Fierce Biotech editorial team and let us know. Feb. 13 - Moderna: The big biotech is revamping its digital team, eliminating 10% of roles under two digital departments ...

There is still plenty of upside left for Vertex Pharmaceuticals, which makes it a top biotech stock to buy this month and hold onto for a while. Moderna is a victim of its own success. The biotech ...

CRISPR Therapeutics AG (CRSP) stock jumped over 9% this week after delivering strong Q4 2024 results ahead of schedule. The ...

Moderna (MRNA) is expected to deliver a year ... a handicapping insight into the odds of a positive EPS surprise. This biotechnology company is expected to post quarterly loss of $2.65 per share ...

The fourth-quarter earnings season for the biotech sector is in full swing this ... before the opening bell. Moderna’s earnings beat estimates in each of the trailing four quarters, delivering ...

The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected ...